Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Black Stone Minerals LP (NY: BSM )

17.50 +0.11 (+0.66%)
Streaming Delayed Price Updated: 10:07 AM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Black Stone Minerals LP

< Previous 1 2 3 Next >
Why BLACK STONE MINERALS LP (NYSE:BSM) qualifies as a quality stock.
BLACK STONE MINERALS LP (NYSE:BSM) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
3 Oil Exploration Stocks To Cushion WTI Swings
Investors can now tweak their portfolios to cushion the uncertainty experienced in WTI prices, by balancing a potential purchase in these 3 high potential names 
Via MarketBeat
Topics Economy
Exposures Economy
3 Very Oversold Dividend Stocks to Buy Right Now
These dividend stocks ranging from asset management to cannabis to natural resources are definitely undervalued and ones to buy now. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Exploring NYSE:BSM's quality characteristics.
BLACK STONE MINERALS LP (NYSE:BSM) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
Analyst Expectations for Black Stone Minerals's Future
Via Benzinga
Black Stone Minerals, L.P. Reports Second Quarter Results
From Black Stone Minerals, L.P.
Via Business Wire
Preview: Black Stone Minerals's Earnings
Via Benzinga
Analyst Expectations for Black Stone Minerals's Future
Via Benzinga
Analyst Expectations for Black Stone Minerals's Future
Via Benzinga
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
Earnings Preview: Black Stone Minerals
Via Benzinga
Black Stone Minerals, L.P. Maintains Second Quarter Distribution for Common Units and Schedules Earnings Call to Discuss Second Quarter 2023 Results
From Black Stone Minerals, L.P.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
Via Benzinga
What 4 Analyst Ratings Have To Say About Black Stone Minerals
Via Benzinga
What 4 Analyst Ratings Have To Say About Black Stone Minerals
Via Benzinga
Overview Of Value Stocks In The Energy Sector
Via Benzinga
A Preview Of Black Stone Minerals's Earnings
Via Benzinga
Black Stone Minerals, L.P. Reports First Quarter Results
From Black Stone Minerals, L.P.
Via Business Wire
Short Volatility Alert: Black Stone Minerals
On Wednesday, shares of Black Stone Minerals (NYSE: BSM) experienced volatile short activity. After the activity, the stock price went down -0.18% to $16.63. The overall sentiment for BSM has been... 
Via Benzinga
Black Stone Minerals, L.P. Declares First Quarter 2023 Distribution for Common Units and Schedules Earnings Call to Discuss First Quarter 2023 Results
From Black Stone Minerals, L.P.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Via Benzinga
Analyst Ratings for Black Stone Minerals
Via Benzinga
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Black Stone Minerals, L.P. Announces Record Fourth Quarter and Full Year 2022 Results; Provides Guidance for 2023
From Black Stone Minerals, L.P.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023
Via Benzinga
RH To Rally Over 15%? Here Are 10 Other Analyst Forecasts For Monday
Citigroup boosted the price target for RH (NYSE: RH) from $305 to $380. Citigroup analyst Steven Zaccone maintained a Buy rating. Hershey shares fell 4% to $330.00 in pre-market trading. 
Via Benzinga
Black Stone Minerals, L.P. Announces Further Distribution Increase and Schedules Earnings Call to Discuss Fourth Quarter and Full-Year 2022 Results
From Black Stone Minerals, L.P.
Via Business Wire
Black Stone Minerals, L.P. Announces Leadership Change
From Black Stone Minerals, L.P.
Via Business Wire
Cramer Is Holding This Biotech Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding Biomarin Pharmaceutical Inc (NASDAQ: BMRN). 
Via Benzinga
Black Stone Minerals, L.P. Reports Record Financial Results for Third Quarter
From Black Stone Minerals, L.P.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.